US Stock MarketDetailed Quotes

SGMO Sangamo Therapeutics

Watchlist
  • 1.972
  • +0.022+1.10%
Trading Nov 21 15:32 ET
411.35MMarket Cap-2776P/E (TTM)

Sangamo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
124.86%11.76M
55.72%-26.88M
26.60%-48.66M
-0.54%-224.84M
11.41%-50.54M
11.80%-47.29M
-12.46%-60.71M
-12.42%-66.3M
4.13%-223.63M
-8.22%-57.05M
Net income from continuing operations
110.25%10.67M
68.45%-36.13M
-332.29%-49.09M
-34.09%-257.83M
-16.01%-60.3M
-95.96%-104.16M
-165.23%-114.51M
148.05%21.13M
-7.84%-192.28M
-38.61%-51.97M
Depreciation and amortization
-71.33%2.13M
-58.38%2.57M
-54.74%2.53M
7.93%22.19M
-44.69%3.01M
43.22%7.42M
23.57%6.18M
13.02%5.58M
16.58%20.56M
11.96%5.44M
Deferred tax
-90.11%18K
----
----
---6.34M
---140K
--182K
----
----
--0
--0
Other non cash items
--99K
----
----
--1.12M
--0
----
----
----
----
----
Change In working capital
-67.30%-4.47M
176.19%2.54M
94.40%-8.9M
-99.27%-164.03M
104.39%783K
79.29%-2.67M
85.99%-3.33M
-471.46%-158.81M
19.21%-82.32M
19.45%-17.85M
-Change in receivables
-552.31%-9.88M
-96.94%126K
116.38%586K
66.51%3.15M
-25.96%425K
75.50%2.19M
310.17%4.11M
-283.80%-3.58M
1,934.95%1.89M
-74.20%574K
-Change in prepaid assets
829.56%2.84M
744.15%4.35M
-112.58%-783K
224.93%6.13M
3.73%974K
54.56%-389K
85.79%-675K
2,682.16%6.22M
31.58%-4.91M
232.63%939K
-Change in payables and accrued expense
97.83%-137K
-61.58%2.84M
28.62%-7.5M
-58.13%5.59M
283.89%14.99M
-161.38%-6.3M
267.07%7.4M
-391.05%-10.5M
274.16%13.35M
231.70%3.91M
-Change in other current liabilities
-2.27%-1.26M
-31.73%-1.59M
-0.84%-1.2M
-123.96%-5.06M
-251.53%-1.43M
-6.95%-1.23M
-9.55%-1.2M
-24.87%-1.19M
27.72%-2.26M
185.83%945K
-Change in other working capital
29.58%3.97M
----
----
-92.33%-173.85M
41.45%-14.18M
113.67%3.06M
10.55%-12.97M
-411.60%-149.77M
-7.83%-90.39M
-23.48%-24.21M
Cash from discontinued investing activities
Operating cash flow
124.86%11.76M
55.72%-26.88M
26.60%-48.66M
-0.54%-224.84M
11.41%-50.54M
11.80%-47.29M
-12.46%-60.71M
-12.42%-66.3M
4.13%-223.63M
-8.22%-57.05M
Investing cash flow
Cash flow from continuing investing activities
-99.38%233K
-99.70%127K
0.31%35.84M
158.97%153.53M
-11.51%37.71M
379.51%37.63M
49.38%42.47M
1,995.48%35.73M
-76.11%59.29M
-19.04%42.61M
Net PPE purchase and sale
95.81%-115K
--0
--0
-4.88%-21.16M
64.26%-2.67M
37.82%-2.74M
-1.74%-5.54M
-259.28%-10.2M
13.35%-20.17M
-161.51%-7.47M
Net business purchase and sale
----
----
----
--0
----
----
----
----
--0
----
Net investment purchase and sale
--0
--0
-21.96%35.84M
119.85%174.69M
-19.38%40.38M
546.14%40.37M
41.73%48.01M
910.74%45.93M
-70.74%79.46M
-9.74%50.09M
Net other investing changes
--348K
----
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
-99.38%233K
-99.70%127K
0.31%35.84M
158.97%153.53M
-11.51%37.71M
379.51%37.63M
49.38%42.47M
1,995.48%35.73M
-76.11%59.29M
-19.04%42.61M
Financing cash flow
Cash flow from continuing financing activities
-103.00%-203K
-108.18%-533K
176.46%22.12M
-82.77%14.59M
-99.15%167K
-100.23%-100K
-71.50%6.52M
610.66%8M
157.65%84.66M
824.95%19.54M
Net common stock issuance
--0
-110.01%-600K
147.22%22.52M
-82.20%15.11M
--0
-100.00%1K
-72.67%5.99M
--9.11M
213.18%84.87M
--17.91M
Proceeds from stock option exercised by employees
--0
----
----
-50.66%935K
-87.80%216K
--0
----
----
-78.98%1.9M
-25.65%1.77M
Net other financing activities
-100.99%-203K
59.28%-79K
63.75%-402K
30.94%-1.45M
65.49%-49K
25.19%-101K
-4.30%-194K
32.42%-1.11M
35.42%-2.1M
47.41%-142K
Cash from discontinued financing activities
Financing cash flow
-103.00%-203K
-108.18%-533K
176.46%22.12M
-82.77%14.59M
-99.15%167K
-100.23%-100K
-71.50%6.52M
610.66%8M
157.65%84.66M
824.95%19.54M
Net cash flow
Beginning cash position
-59.34%27.79M
-30.61%55.33M
-54.19%46.7M
-43.48%101.94M
-39.61%58.01M
-42.68%68.33M
-34.51%79.74M
-43.48%101.94M
35.79%180.37M
-46.17%96.07M
Current changes in cash
220.71%11.79M
-132.77%-27.29M
141.20%9.3M
28.81%-56.72M
-348.34%-12.66M
58.02%-9.77M
-337.14%-11.72M
61.64%-22.57M
-266.68%-79.68M
150.81%5.1M
Effect of exchange rate changes
304.73%1.13M
-182.11%-257K
-282.56%-670K
18.26%1.48M
74.58%1.35M
-533.07%-550K
140.77%313K
65.32%367K
576.81%1.25M
773.91%775K
End cash Position
-29.84%40.7M
-59.34%27.79M
-30.61%55.33M
-54.19%46.7M
-54.19%46.7M
-39.61%58.01M
-42.68%68.33M
-34.51%79.74M
-43.48%101.94M
-43.48%101.94M
Free cash flow
123.27%11.64M
59.42%-26.88M
36.39%-48.66M
-0.90%-246M
17.53%-53.21M
13.78%-50.04M
-11.48%-66.25M
-23.76%-76.5M
4.96%-243.8M
-16.11%-64.52M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 124.86%11.76M55.72%-26.88M26.60%-48.66M-0.54%-224.84M11.41%-50.54M11.80%-47.29M-12.46%-60.71M-12.42%-66.3M4.13%-223.63M-8.22%-57.05M
Net income from continuing operations 110.25%10.67M68.45%-36.13M-332.29%-49.09M-34.09%-257.83M-16.01%-60.3M-95.96%-104.16M-165.23%-114.51M148.05%21.13M-7.84%-192.28M-38.61%-51.97M
Depreciation and amortization -71.33%2.13M-58.38%2.57M-54.74%2.53M7.93%22.19M-44.69%3.01M43.22%7.42M23.57%6.18M13.02%5.58M16.58%20.56M11.96%5.44M
Deferred tax -90.11%18K-----------6.34M---140K--182K----------0--0
Other non cash items --99K----------1.12M--0--------------------
Change In working capital -67.30%-4.47M176.19%2.54M94.40%-8.9M-99.27%-164.03M104.39%783K79.29%-2.67M85.99%-3.33M-471.46%-158.81M19.21%-82.32M19.45%-17.85M
-Change in receivables -552.31%-9.88M-96.94%126K116.38%586K66.51%3.15M-25.96%425K75.50%2.19M310.17%4.11M-283.80%-3.58M1,934.95%1.89M-74.20%574K
-Change in prepaid assets 829.56%2.84M744.15%4.35M-112.58%-783K224.93%6.13M3.73%974K54.56%-389K85.79%-675K2,682.16%6.22M31.58%-4.91M232.63%939K
-Change in payables and accrued expense 97.83%-137K-61.58%2.84M28.62%-7.5M-58.13%5.59M283.89%14.99M-161.38%-6.3M267.07%7.4M-391.05%-10.5M274.16%13.35M231.70%3.91M
-Change in other current liabilities -2.27%-1.26M-31.73%-1.59M-0.84%-1.2M-123.96%-5.06M-251.53%-1.43M-6.95%-1.23M-9.55%-1.2M-24.87%-1.19M27.72%-2.26M185.83%945K
-Change in other working capital 29.58%3.97M---------92.33%-173.85M41.45%-14.18M113.67%3.06M10.55%-12.97M-411.60%-149.77M-7.83%-90.39M-23.48%-24.21M
Cash from discontinued investing activities
Operating cash flow 124.86%11.76M55.72%-26.88M26.60%-48.66M-0.54%-224.84M11.41%-50.54M11.80%-47.29M-12.46%-60.71M-12.42%-66.3M4.13%-223.63M-8.22%-57.05M
Investing cash flow
Cash flow from continuing investing activities -99.38%233K-99.70%127K0.31%35.84M158.97%153.53M-11.51%37.71M379.51%37.63M49.38%42.47M1,995.48%35.73M-76.11%59.29M-19.04%42.61M
Net PPE purchase and sale 95.81%-115K--0--0-4.88%-21.16M64.26%-2.67M37.82%-2.74M-1.74%-5.54M-259.28%-10.2M13.35%-20.17M-161.51%-7.47M
Net business purchase and sale --------------0------------------0----
Net investment purchase and sale --0--0-21.96%35.84M119.85%174.69M-19.38%40.38M546.14%40.37M41.73%48.01M910.74%45.93M-70.74%79.46M-9.74%50.09M
Net other investing changes --348K------------------------------------
Cash from discontinued investing activities
Investing cash flow -99.38%233K-99.70%127K0.31%35.84M158.97%153.53M-11.51%37.71M379.51%37.63M49.38%42.47M1,995.48%35.73M-76.11%59.29M-19.04%42.61M
Financing cash flow
Cash flow from continuing financing activities -103.00%-203K-108.18%-533K176.46%22.12M-82.77%14.59M-99.15%167K-100.23%-100K-71.50%6.52M610.66%8M157.65%84.66M824.95%19.54M
Net common stock issuance --0-110.01%-600K147.22%22.52M-82.20%15.11M--0-100.00%1K-72.67%5.99M--9.11M213.18%84.87M--17.91M
Proceeds from stock option exercised by employees --0---------50.66%935K-87.80%216K--0---------78.98%1.9M-25.65%1.77M
Net other financing activities -100.99%-203K59.28%-79K63.75%-402K30.94%-1.45M65.49%-49K25.19%-101K-4.30%-194K32.42%-1.11M35.42%-2.1M47.41%-142K
Cash from discontinued financing activities
Financing cash flow -103.00%-203K-108.18%-533K176.46%22.12M-82.77%14.59M-99.15%167K-100.23%-100K-71.50%6.52M610.66%8M157.65%84.66M824.95%19.54M
Net cash flow
Beginning cash position -59.34%27.79M-30.61%55.33M-54.19%46.7M-43.48%101.94M-39.61%58.01M-42.68%68.33M-34.51%79.74M-43.48%101.94M35.79%180.37M-46.17%96.07M
Current changes in cash 220.71%11.79M-132.77%-27.29M141.20%9.3M28.81%-56.72M-348.34%-12.66M58.02%-9.77M-337.14%-11.72M61.64%-22.57M-266.68%-79.68M150.81%5.1M
Effect of exchange rate changes 304.73%1.13M-182.11%-257K-282.56%-670K18.26%1.48M74.58%1.35M-533.07%-550K140.77%313K65.32%367K576.81%1.25M773.91%775K
End cash Position -29.84%40.7M-59.34%27.79M-30.61%55.33M-54.19%46.7M-54.19%46.7M-39.61%58.01M-42.68%68.33M-34.51%79.74M-43.48%101.94M-43.48%101.94M
Free cash flow 123.27%11.64M59.42%-26.88M36.39%-48.66M-0.90%-246M17.53%-53.21M13.78%-50.04M-11.48%-66.25M-23.76%-76.5M4.96%-243.8M-16.11%-64.52M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Gene Editing
Gene Editing
Intraday+0.32%